UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Frontiers in physiology, 2021-03, Vol.12, p.632260-632260

2021

Volltextzugriff (PDF)

Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

American journal of nephrology, 2020-04, Vol.51 (4), p.294-303

2020

Volltextzugriff (PDF)

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Diabetes, obesity & metabolism, 2023-10, Vol.25 (10), p.2989-2998

2023

Volltextzugriff (PDF)

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

Pharmaceuticals (Basel, Switzerland), 2024-09, Vol.17 (10), p.1299

2024

Volltextzugriff (PDF)

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

BMJ open, 2024-03, Vol.14 (3), p.e076444-e076444

2024

Volltextzugriff (PDF)

Physical Exercise in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Frontiers in cardiovascular medicine, 2022-05, Vol.9, p.893811-893811

2022

Volltextzugriff (PDF)

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets

Frontiers in physiology, 2021-11, Vol.12, p.775029-775029

2021

Volltextzugriff (PDF)

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

European heart journal, 2023-06, Vol.44 (21), p.1874-1889

2023

Volltextzugriff (PDF)

Lifestyle interventions for the prevention and treatment of hypertension

Nature reviews cardiology, 2021-04, Vol.18 (4), p.251-275

2021

Volltextzugriff (PDF)

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

Scientific reports, 2017-08, Vol.7 (1), p.8894-11, Article 8894

2017

Volltextzugriff (PDF)

Gestational Exercise and Maternal and Child Health: Effects until Delivery and at Post-Natal Follow-up

Journal of clinical medicine, 2020-01, Vol.9 (2), p.379

2020

Volltextzugriff (PDF)

The year in cardiovascular medicine 2020: epidemiology and prevention

European heart journal, 2021-02, Vol.42 (8), p.813-821

2021

Volltextzugriff (PDF)

Association between physical activity and cardiovascular risk factors: Dose and sex matter

Journal of sport and health science, 2021-09, Vol.10 (5), p.604-606

2021

Volltextzugriff (PDF)

Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease

Hypertension research, 2020-07, Vol.43 (7), p.696-704

2020

Volltextzugriff (PDF)

Urinary extracellular vesicles as a monitoring tool for renal damage in patients not meeting criteria for chronic kidney disease

Journal of extracellular biology, 2024-09, Vol.3 (9), p.e170-n/a

2024

Volltextzugriff (PDF)

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension

Antioxidants, 2021-07, Vol.10 (7), p.1100

2021

Volltextzugriff (PDF)

Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9-Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA

Frontiers in immunology, 2017-07, Vol.8, p.853-853

2017

Volltextzugriff (PDF)

Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

European heart journal, 2021-10, Vol.42 (40), p.4123-4125

2021

Volltextzugriff (PDF)

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

Kidney medicine, 2023-12, Vol.5 (12), p.100730-100730, Article 100730

2023

Volltextzugriff (PDF)

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Hypertension (Dallas, Tex. 1979), 2022-12, Vol.79 (12), p.2685-2695

2022

Volltextzugriff (PDF)

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Kidney medicine, 2023-10, Vol.5 (10), p.100704-100704, Article 100704

2023

Volltextzugriff (PDF)

Resistant Hypertension and Mortality: An Observational Cohort Study

Hypertension (Dallas, Tex. 1979), 2024-11, Vol.81 (11), p.2350-2356

2024

Volltextzugriff (PDF)

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years

Nephrology, dialysis, transplantation, 2022-01, Vol.37 (2), p.304-310

2022

Volltextzugriff (PDF)

Prognostic Value of Masked Uncontrolled Hypertension: Systematic Review and Meta-Analysis

Hypertension (Dallas, Tex. 1979), 2018-10, Vol.72 (4), p.862-869

2018

Volltextzugriff (PDF)

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology, dialysis, transplantation, 2022-06, Vol.37 (7), p.1261-1269

2022

Volltextzugriff (PDF)

1 – 25 von 424

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaBlood Pressure - Drug Effects

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(393)
Mit Volltextzugriff
(375)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

An Overview of FGF-23 as a Novel Candidate Biomarker of Cardiovascular Risk

Finerenone Reduces Intrinsic Arterial Stiffness in Munich Wistar Frömter Rats, a Genetic Model of Chronic Kidney Disease

The impact of obesity on cardiovascular and kidney outcomes in patients with chronic kidney disease and type 2 diabetes treated with finerenone: Post hoc analysis of the FIDELITY study

Glucose-Lowering Drugs and Primary Prevention of Chronic Kidney Disease in Type 2 Diabetes Patients: A Real-World Primary Care Study

Finerenone cardiovascular and kidney outcomes by age and sex: FIDELITY post hoc analysis of two phase 3, multicentre, double-blind trials

Physical Exercise in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Fibroblast Growth Factor-23-Klotho Axis in Cardiorenal Syndrome: Mediators and Potential Therapeutic Targets

Exercise benefits in cardiovascular diseases: from mechanisms to clinical implementation

Lifestyle interventions for the prevention and treatment of hypertension

Immune system deregulation in hypertensive patients chronically RAS suppressed developing albuminuria

Gestational Exercise and Maternal and Child Health: Effects until Delivery and at Post-Natal Follow-up

The year in cardiovascular medicine 2020: epidemiology and prevention

Association between physical activity and cardiovascular risk factors: Dose and sex matter

Prevalence of office and ambulatory hypotension in treated hypertensive patients with coronary disease

Urinary extracellular vesicles as a monitoring tool for renal damage in patients not meeting criteria for chronic kidney disease

TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension

Rapid, Automated, and Specific Immunoassay to Directly Measure Matrix Metalloproteinase-9-Tissue Inhibitor of Metalloproteinase-1 Interactions in Human Plasma Using AlphaLISA Technology: A New Alternative to Classical ELISA

Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

Resistant Hypertension and Mortality: An Observational Cohort Study

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years

Prognostic Value of Masked Uncontrolled Hypertension: Systematic Review and Meta-Analysis

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post-hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Aktive Filter

Suchergebnisse filtern